Drugs / Mitomycin (MMC)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2/3 | NCT00626782 Comparator | Jan 2008 → Apr 2011 | glaucoma | Wills Eye | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Mitomycin (MMC) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00626782 ↗ |
| Known as | mitomycin C | “mitomycin C (MMC), but it is associated with well known complications.” PMID 25019269 ↗ Jul 2014 |